Literature DB >> 3864157

Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid.

N Ling, S Y Ying, N Ueno, F Esch, L Denoroy, R Guillemin.   

Abstract

A Mr 32,000 protein with inhibin activity was isolated from porcine follicular fluid by heparin-Sepharose affinity chromatography, gel filtration on Sephacryl S-200, and four reversed-phase HPLC steps. The isolated molecule is composed of two chains having molecular weights of 18,000 and 14,000, respectively, and bound together by disulfide bonds. Amino acid sequence analysis revealed the 10 NH2-terminal residues of the Mr 18,000 chain to be Ser-Thr-Ala-Pro-Leu-Pro-Trp-Pro-Trp-Ser- and those of the Mr 14,000 chain to be Gly-Leu-Glu-Xaa-Asp-Gly-Arg-Thr-Asn-Leu-. This Mr 32,000 protein specifically inhibits the basal secretion of FSH, but not that of LH, in the rat anterior pituitary monolayer culture system, with a half-maximal effective dose of 450 pg/ml.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3864157      PMCID: PMC390820          DOI: 10.1073/pnas.82.21.7217

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  DUAL ENDOCRINE ACTIVITY OF THE TESTES.

Authors:  D R McCullagh
Journal:  Science       Date:  1932-07-01       Impact factor: 47.728

Review 2.  Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays.

Authors:  D Rodbard
Journal:  Clin Chem       Date:  1974-10       Impact factor: 8.327

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Amino acid sequence of the predominant basic protein in human seminal plasma.

Authors:  H Lilja; J O Jeppsson
Journal:  FEBS Lett       Date:  1985-03-11       Impact factor: 4.124

5.  High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides.

Authors:  P Böhlen; R Schroeder
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

6.  Isolation of porcine follicular fluid inhibin of 32K daltons.

Authors:  K Miyamoto; Y Hasegawa; M Fukuda; M Nomura; M Igarashi; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1985-06-14       Impact factor: 3.575

7.  Isolation, structure, and synthesis of a human seminal plasma peptide with inhibin-like activity.

Authors:  K Ramasharma; M R Sairam; N G Seidah; M Chrétien; P Manjunath; P W Schiller; D Yamashiro; C H Li
Journal:  Science       Date:  1984-03-16       Impact factor: 47.728

8.  Polypeptide microsequence analysis with the commercially available gas-phase sequencer.

Authors:  F S Esch
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

9.  Evidence for ovarian "inhibin": suppression of the secondary rise in serum follicle stimulating hormone levels in proestrous rats by injection of porcine follicular fluid.

Authors:  N B Schwartz; C P Channing
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  beta 2-Inhibin contains the active core of human seminal plasma beta-inhibin: synthesis and bioactivity.

Authors:  N J Arbatti; N G Seidah; J Rochemont; E Escher; A R Sheth; M Chrétien
Journal:  FEBS Lett       Date:  1985-02-11       Impact factor: 4.124

View more
  42 in total

Review 1.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

2.  Activin A suppresses osteoblast mineralization capacity by altering extracellular matrix (ECM) composition and impairing matrix vesicle (MV) production.

Authors:  Rodrigo D A M Alves; Marco Eijken; Karel Bezstarosti; Jeroen A A Demmers; Johannes P T M van Leeuwen
Journal:  Mol Cell Proteomics       Date:  2013-06-17       Impact factor: 5.911

3.  Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related.

Authors:  S Y Ying; J Czvik; A Becker; N Ling; N Ueno; R Guillemin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Characteristics of binding of human seminal alpha-inhibin-92 to human pituitary membranes.

Authors:  K Ramasharma; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  Inhibin A-subunit cDNAs from porcine ovary and human placenta.

Authors:  K E Mayo; G M Cerelli; J Spiess; J Rivier; M G Rosenfeld; R M Evans; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  DNA methylation and histone modifications are associated with repression of the inhibin α promoter in the rat corpus luteum.

Authors:  Kristen M Meldi; Georgia A Gaconnet; Kelly E Mayo
Journal:  Endocrinology       Date:  2012-08-03       Impact factor: 4.736

Review 7.  Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons: a new tool for dissecting the molecular and cellular basis of LHRH physiology.

Authors:  W C Wetsel
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

8.  Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells.

Authors:  F Petraglia; J Vaughan; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  An activin/furin regulatory loop modulates the processing and secretion of inhibin alpha- and betaB-subunit dimers in pituitary gonadotrope cells.

Authors:  Monica Antenos; Jie Zhu; Niti M Jetly; Teresa K Woodruff
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

10.  Changes in the reproductive function and developmental phenotypes in mice following intramuscular injection of an activin betaA-expressing plasmid.

Authors:  Mi-Nyeu Kim; Moon Nyeo Park; Hoi Kyung Jung; Chunghee Cho; Kelly E Mayo; Byung-Nam Cho
Journal:  Reprod Biol Endocrinol       Date:  2008-12-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.